False-Negative Serum Cryptococcal Antigen Lateral Flow Immunoassay Result for a Patient with Disseminated Cryptococcal Disease

References

• Pappas PG, Alexander BD, Andes DR, et al. Invasive fungal infections among organ transplant recipients: results of the transplant-associated infection surveillance network (Transnet). Clin Infect Dis. 2010;50(8):1101–1111. doi:10.1086/65126220218876
   PubMed Web of Science ®Google Scholar
• Nawrot U, Kowalska-Krochmal B, Sulik-Tyszka B, et al. Evaluation of blood culture media for the detection of fungi. Eur J Clin Microbiol Infect Dis. 2015;34(1):161–167. doi:10.1007/s10096-014-2218-425098681
   PubMed Web of Science ®Google Scholar
• Zhou Y, Lin PC, Ye JR, et al. The performance of serum cryptococcal capsular polysaccharide antigen test, histopathology and culture of the lung tissue for diagnosis of pulmonary cryptococcosis in patients without HIV infection. Infect Drug Resist. 2018;11:2483–2490. doi:10.2147/IDR.S17839130555247
   PubMed Web of Science ®Google Scholar
• Espinel-Ingroff A, Aller AI, Canton E, et al. Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole. Antimicrob Agents Chemother. 2012;56(11):5898–5906. doi:10.1128/AAC.01115-1222948877
   PubMed Web of Science ®Google Scholar
• Espinel-Ingroff A, Chowdhary A, Cuenca-Estrella M, et al. Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine. Antimicrob Agents Chemother. 2012;56(6):3107–3113. doi:10.1128/AAC.06252-1122391546
   PubMed Web of Science ®Google Scholar
• Espinel-Ingroff A, Chowdhary A, Gonzalez GM, et al. Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for the Cryptococcus neoformans-Cryptococcus gattii species complex using the CLSI M27-A3 broth microdilution method. Antimicrob Agents Chemother. 2015;59(1):666–668. doi:10.1128/AAC.04055-1425313209
   PubMed Web of Science ®Google Scholar
• Makadzange AT, McHugh G. New approaches to the diagnosis and treatment of cryptococcal meningitis. Semin Neurol. 2014;34(1):47–60. doi:10.1055/s-0034-137234224715488
   PubMed Web of Science ®Google Scholar
• Saha DC, Xess I, Biswas A, Bhowmik DM, Padma MV. Detection of Cryptococcus by conventional, serological and molecular methods. J Med Microbiol. 2009;58(Pt 8):1098–1105. doi:10.1099/jmm.0.007328-019528182
   PubMed Web of Science ®Google Scholar
• Temfack E, Boyer-Chammard T, Lawrence D, et al. New insights into cryptococcus spp. biology and cryptococcal meningitis. Curr Neurol Neurosci Rep. 2019;19(10):81. doi:10.1007/s11910-019-0993-031673881
   PubMed Web of Science ®Google Scholar
• Bloomfield N, Gordon MA, Elmendorf DF Jr. Detection of cryptococcus neoformans antigen in body fluids by latex particle agglutination. Proc Soc Exp Biol Med. 1963;114:64–67. doi:10.3181/00379727-114-2858614076914
   PubMed Web of Science ®Google Scholar
• Vidal JE, Boulware DR. Lateral flow assay for cryptococcal antigen: an important advance to improve the continuum of HIV care and reduce cryptococcal meningitis-related mortality. Rev Inst Med Trop Sao Paulo. 2015;57(Suppl 19):38–45. doi:10.1590/S0036-4665201500070000826465368
   PubMed Web of Science ®Google Scholar
• Caceres DH, Zuluaga A, Tabares AM, Chiller T, Gonzalez A, Gomez BL. Evaluation of a cryptococcal antigen lateral flow assay in serum and cerebrospinal fluid for rapid diagnosis of cryptococcosis in Colombia. Rev Inst Med Trop Sao Paulo. 2017;59:e76. doi:10.1590/s1678-994620175907629267584
   PubMed Web of Science ®Google Scholar
• Mahajan KR, Roberts AL, Curtis MT, Fortuna D, Dharia R, Sheehan L. Diagnostic challenges of cryptococcus neoformans in an immunocompetent individual masquerading as chronic hydrocephalus. Case Rep Neurol Med. 2016;2016:7381943.27525140
   PubMedGoogle Scholar
• Borges M, Araujo Filho JA, Soares RBA, Vidal JE, Turchi MD. False-negative result of serum cryptococcal antigen lateral flow assay in an HIV-infected patient with culture-proven cryptococcaemia. Med Mycol Case Rep. 2019;26:64–66. doi:10.1016/j.mmcr.2019.10.00931737475
   PubMed Web of Science ®Google Scholar
• Yadava SK, Fazili T. Postzone phenomenon resulting in a false-negative cerebral spinal fluid cryptococcal antigen lateral flow assay. AIDS. 2019;33(6):1099–1100. doi:10.1097/QAD.000000000000215730946166
   PubMed Web of Science ®Google Scholar
• Lourens A, Jarvis JN, Meintjes G, Samuel CM. Rapid diagnosis of cryptococcal meningitis by use of lateral flow assay on cerebrospinal fluid samples: influence of the high-dose “hook” effect. J Clin Microbiol. 2014;52(12):4172–4175. doi:10.1128/JCM.01683-1425232153
   PubMed Web of Science ®Google Scholar
• Kojima N, Chimombo M, Kahn DG. False-negative cryptococcal antigen test due to the postzone phenomenon. AIDS. 2018;32(9):1201–1202. doi:10.1097/QAD.000000000000180529746320
   PubMed Web of Science ®Google Scholar
• Currie BP, Freundlich LF, Soto MA, Casadevall A. False-negative cerebrospinal fluid cryptococcal latex agglutination tests for patients with culture-positive cryptococcal meningitis. J Clin Microbiol. 1993;31(9):2519–2522. doi:10.1128/JCM.31.9.2519-2522.19938408579
   PubMed Web of Science ®Google Scholar
• Jarvis JN, Percival A, Bauman S, et al. Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis. Clin Infect Dis. 2011;53(10):1019–1023. doi:10.1093/cid/cir61321940419
   PubMed Web of Science ®Google Scholar
• Saag MS, Graybill RJ, Larsen RA, et al. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis. 2000;30(4):710–718. doi:10.1086/31375710770733
   PubMed Web of Science ®Google Scholar